Medicare will cover weight-loss drugs under a deal between the Trump administration and drugmakers Eli Lilly and Novo Nordisk to cut prices for blockbuster diabetes and anti-obesity drugs. Why it ...
WASHINGTON – On November 6, 2025, U.S. Senators Amy Klobuchar (D-MN) released the following statement in response to Eli Lilly and Novo Nordisk’s newly negotiated prices for weight loss drugs for ...
As President Donald Trump touts new deals to cut the cost of blockbuster drugs like Wegovy and Zepbound, he’s barely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback